regeneron pharmaceuticals semaglutide announced on January 30, 2026, that its experimental obesity drug candidate delivers significant cholesterol-lowering benefits on top of weight loss—a differentiation strategy aimed at competing with Eli Lilly's and Semaglutide GLP-1 Receptor Agonist Research

Timing your medication injection or oral dose relative to your eating window matters less than consistency and hydration

Brush MH, Guardiola A, Connor JH, Yao TP, Shenolikar S

No serious systemic adverse events have been documented in peer-reviewed human studies at therapeutic doses

ELEVATE STRENGTH STAMINA: A much-needed energy powder boost for higher energy levels, greater stamina, and overall mood improvement

For information about supplements that have been investigated in humans for athletic performance and joint health, see our Reviews of Muscle and Workout Supplements , Collagen Supplements , Nitric Oxide Supplements , and Joint Health Supplements